Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128916754> ?p ?o ?g. }
- W2128916754 endingPage "423" @default.
- W2128916754 startingPage "416" @default.
- W2128916754 abstract "CLL is characterized by a dynamic balance between cells proliferating in the lymphoid organs and circulating cells resisting programmed cell death. Regulating this equilibrium entails complex interactions between tumor and host, modulated by a set of surface molecules expressed by the CLL cell according to environmental conditions. The result is a constantly shifting pattern of resistance, apoptosis and proliferation. The CD38 surface molecule is an independent negative prognostic factor expressed by approximately one-third of CLL patients. Our view is that CD38 is crucial to tumor-host communication and that its signals are detrimental to clinical outcome. CD38(+) CLL cells can proliferate in vitro in the presence of anti-CD38 mAbs and IL-2 and are more sensitive to the effects of the CXCL12 chemokine. Blockage of CD38 signals impairs CLL cell movement from blood to lymphoid organs, as confirmed using animal models. One model to be explored considers CD38 a key component of the CLL invadosome, a still hypothetical membrane domain containing adhesion molecules, chemokine receptors and matrix metalloproteases. Some components of the invadosome are genetically polymorphic, explaining heterogeneity in functional response. The CD38 gene shows genetic differences in the promoter region, some of which represent an independent risk for Richter transformation. In addition to driving the clinical outcome of the disease, CD38 is thus an excellent candidate therapeutic target for a significant subset of CLL patients." @default.
- W2128916754 created "2016-06-24" @default.
- W2128916754 creator A5007447330 @default.
- W2128916754 creator A5012114658 @default.
- W2128916754 creator A5020633332 @default.
- W2128916754 creator A5068535005 @default.
- W2128916754 creator A5073179633 @default.
- W2128916754 date "2010-12-01" @default.
- W2128916754 modified "2023-09-25" @default.
- W2128916754 title "CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells" @default.
- W2128916754 cites W100209535 @default.
- W2128916754 cites W1243376384 @default.
- W2128916754 cites W131012821 @default.
- W2128916754 cites W1429374962 @default.
- W2128916754 cites W1531083786 @default.
- W2128916754 cites W1537242998 @default.
- W2128916754 cites W1559286577 @default.
- W2128916754 cites W1560040722 @default.
- W2128916754 cites W1574887471 @default.
- W2128916754 cites W1679944210 @default.
- W2128916754 cites W1969487650 @default.
- W2128916754 cites W1975579949 @default.
- W2128916754 cites W1976151361 @default.
- W2128916754 cites W1976978160 @default.
- W2128916754 cites W1986321004 @default.
- W2128916754 cites W1987171087 @default.
- W2128916754 cites W1989917641 @default.
- W2128916754 cites W1990364254 @default.
- W2128916754 cites W1991988527 @default.
- W2128916754 cites W2002127956 @default.
- W2128916754 cites W2006368533 @default.
- W2128916754 cites W2007627691 @default.
- W2128916754 cites W2010658521 @default.
- W2128916754 cites W2015906906 @default.
- W2128916754 cites W2020855398 @default.
- W2128916754 cites W2021779926 @default.
- W2128916754 cites W2022054497 @default.
- W2128916754 cites W2022864156 @default.
- W2128916754 cites W2024250991 @default.
- W2128916754 cites W2025001077 @default.
- W2128916754 cites W2028774140 @default.
- W2128916754 cites W2029935664 @default.
- W2128916754 cites W2034156576 @default.
- W2128916754 cites W2037751912 @default.
- W2128916754 cites W2041520207 @default.
- W2128916754 cites W2046876844 @default.
- W2128916754 cites W2047350789 @default.
- W2128916754 cites W2054236659 @default.
- W2128916754 cites W2061984547 @default.
- W2128916754 cites W2067543141 @default.
- W2128916754 cites W2067577146 @default.
- W2128916754 cites W2070014828 @default.
- W2128916754 cites W2072810750 @default.
- W2128916754 cites W2078344536 @default.
- W2128916754 cites W2080951919 @default.
- W2128916754 cites W2086337788 @default.
- W2128916754 cites W2086790430 @default.
- W2128916754 cites W2086809581 @default.
- W2128916754 cites W2087441379 @default.
- W2128916754 cites W2087963453 @default.
- W2128916754 cites W2090279266 @default.
- W2128916754 cites W2091285142 @default.
- W2128916754 cites W2099348990 @default.
- W2128916754 cites W2104235597 @default.
- W2128916754 cites W2113751763 @default.
- W2128916754 cites W2122624383 @default.
- W2128916754 cites W2123895023 @default.
- W2128916754 cites W2126482035 @default.
- W2128916754 cites W2130102591 @default.
- W2128916754 cites W2130494719 @default.
- W2128916754 cites W2132129352 @default.
- W2128916754 cites W2134139148 @default.
- W2128916754 cites W2135521078 @default.
- W2128916754 cites W2136557556 @default.
- W2128916754 cites W2137527877 @default.
- W2128916754 cites W2138298517 @default.
- W2128916754 cites W2142589520 @default.
- W2128916754 cites W2147782935 @default.
- W2128916754 cites W2151952748 @default.
- W2128916754 cites W2154992334 @default.
- W2128916754 cites W2155340827 @default.
- W2128916754 cites W2158509187 @default.
- W2128916754 cites W2164323857 @default.
- W2128916754 cites W2169026411 @default.
- W2128916754 cites W2171470834 @default.
- W2128916754 cites W2345680323 @default.
- W2128916754 cites W2408955560 @default.
- W2128916754 cites W4313379456 @default.
- W2128916754 cites W4313429308 @default.
- W2128916754 doi "https://doi.org/10.1016/j.semcancer.2010.08.003" @default.
- W2128916754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20817095" @default.
- W2128916754 hasPublicationYear "2010" @default.
- W2128916754 type Work @default.
- W2128916754 sameAs 2128916754 @default.
- W2128916754 citedByCount "31" @default.
- W2128916754 countsByYear W21289167542012 @default.
- W2128916754 countsByYear W21289167542013 @default.
- W2128916754 countsByYear W21289167542014 @default.